<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05032573</url>
  </required_header>
  <id_info>
    <org_study_id>IRB202100950</org_study_id>
    <nct_id>NCT05032573</nct_id>
  </id_info>
  <brief_title>Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia</brief_title>
  <official_title>Reducing Facial Pain With an Olive Oil Enriched Diet: A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 16-week non-blinded, parallel, controlled trial to determine the feasibility and&#xD;
      potential efficacy of an olive oil dietary intervention to alleviate facial pain caused by&#xD;
      trigeminal neuralgia type 1 (TGN).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trigeminal neuralgia (TGN) pain is debilitating and unpredictable. Alleviation of intensity&#xD;
      or frequency to any degree will improve the quality of life of the individuals affected.&#xD;
      Current medical treatments for TGN are often not effective. In some cases, the pain is a&#xD;
      result of myelin degeneration. If diet can provide the basic building blocks for myelin&#xD;
      regrowth, then the investigators may be able to reduce facial pain by supporting the myelin&#xD;
      nerve sheath.&#xD;
&#xD;
      Animal studies have shown that a dietary intervention with olive oil favorably impacts myelin&#xD;
      but no human study has been conducted to date. The investigators propose undertaking a&#xD;
      feasibility study to determine if a comparable intervention may work in a similar way in&#xD;
      humans. If olive oil impacts myelin repair, then pain will be decreased by this dietary&#xD;
      intervention and quality of life will be improved. However, it is not known if individuals&#xD;
      with TNG will be able to consume a diet relatively high in olive oil. Feasibility will&#xD;
      include testing the logistics of distributing the olive oil intervention to the study&#xD;
      subjects, incorporation of olive oil into the participants' daily diets, and online/distance&#xD;
      monitoring of compliance and reporting of pain intensity, pain frequency, and quality of&#xD;
      life. This feasibility study will lay the groundwork for potential future studies examining&#xD;
      the efficacy of olive oil on alleviating facial pain caused by TNG and may provide data for a&#xD;
      power analysis for a future interventional trial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance to olive oil intervention</measure>
    <time_frame>12 weeks</time_frame>
    <description>Daily olive oil intake in tablespoons per day.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Trigeminal Neuralgia</condition>
  <arm_group>
    <arm_group_label>Olive Oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Incorporating 60 mL of olive oil into usual diet and Dietary Guidelines recommendations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Guidelines recommendations</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Olive oil and Dietary Guideline recommendations</intervention_name>
    <description>60 mL of olive oil and healthy diet recommendations</description>
    <arm_group_label>Olive Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Guideline recommendations</intervention_name>
    <description>healthy diet recommendations</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosed with Trigeminal Neuralgia&#xD;
&#xD;
          2. Able to provide written informed consent in English&#xD;
&#xD;
          3. Self-identifying females 18-70 years of age&#xD;
&#xD;
          4. Willing to consume 60 mL (4 tablespoons) of olive oil and accommodating dietary&#xD;
             changes, and thereby achieve weight maintenance.&#xD;
&#xD;
          5. Willing to provide information about dietary intake at baseline, at the study&#xD;
             midpoint, and at the end of the study to assess dietary changes.&#xD;
&#xD;
          6. Willing to complete online questionnaires associated with the study.&#xD;
&#xD;
          7. Willing and able to provide a valid social security for study payment purposes.&#xD;
&#xD;
          8. Have access to the internet to complete online questionnaires&#xD;
&#xD;
          9. Willing to maintain confidentiality of the Penn Facial Pain Scale&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Do not meet the above criteria.&#xD;
&#xD;
          2. Currently participating in another interventional clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy J Dahl, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wendy J Dahl, PhD</last_name>
    <phone>352-294-3707</phone>
    <email>wdahl@ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniela Rivero-Mendoza, MS</last_name>
    <phone>352-263-9136</phone>
    <email>crivero@ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Food Science and Human Nutrition Department, University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy J Dahl, PhD</last_name>
      <phone>352-294-3707</phone>
      <email>wdahl@ufl.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 27, 2021</study_first_submitted>
  <study_first_submitted_qc>September 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Florida</investigator_affiliation>
    <investigator_full_name>Wendy Dahl</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigeminal Neuralgia</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

